Blog
RSS FeedPosted by Michael Wonder on 19 Nov 2016
Will NICE "go commercial"?
17 November 2016 - NICE, like the NHS it supports, is looking at how to make big savings. One option ...
Posted by Michael Wonder on 17 Nov 2016
Exciting new MAESTrO feature
18 November 2016 - Users can now develop and export images within the application. ...
Posted by Michael Wonder on 17 Nov 2016
Experts agree private health insurance is broken. But how can it be fixed?
18 November 2016 - Reports from government, consumer groups and health bodies depict an unsustainable system. Possible solutions include phasing out ...
Posted by Michael Wonder on 17 Nov 2016
Meningococcal B vaccine petition to lobby for PBS inclusion receives thousands of signatures
17 November 2016 - A petition lobbying the Federal Government to add the meningococcal B vaccine to the PBS by ...
Posted by Michael Wonder on 17 Nov 2016
Price discount helps give green light for breast cancer drug pertuzumab
17 November 2016 - NICE approves the third breast cancer drug is as many weeks as pertuzumab is recommended to shrink ...
Posted by Michael Wonder on 17 Nov 2016
NICE approves three quarters of CDF group 1 drugs for routine use
17 November 2016 - More than 75% of treatments in the Cancer Drugs Fund which have been looked at again by ...
Posted by Michael Wonder on 16 Nov 2016
Pembrolizumab in lung cancer: evidence of considerable additional benefit
16 November 2016 - Significant advantages when compared to docetaxel. ...
Posted by Michael Wonder on 16 Nov 2016
Trifluridine-tipiracil combination in colorectal cancer: additional benefit only for some patients
16 November 2016 - Low benefit for patients with K-RAS wild type; survival benefits, but significant side effects and missing ...
Posted by Michael Wonder on 16 Nov 2016
Japan government panel halves price of cancer drug Opdivo
16 November 2016 - In an unprecedented move, a government panel decided Wednesday to cut the official price of cancer ...
Posted by Michael Wonder on 16 Nov 2016
Proposal to list oral betaine for rare disorder
16 November 2016 - PHARMAC is seeking feedback on a proposal to list betaine (Cystadane) resulting from a provisional agreement ...
Posted by Michael Wonder on 15 Nov 2016
NICE says pancreatic cancer treatment considered not cost effective for routine NHS use
15 November 2016 - The drug pegylated liposomal irinotecan, was not clinically effective enough to justify its high cost, NICE says ...
Posted by Michael Wonder on 15 Nov 2016
NICE publishes draft guidance on the use of Cinqaero (reslizumab)
15 November 2016 - NICE has published draft guidance on the use of reslizumab on the NHS. ...
Posted by Michael Wonder on 15 Nov 2016
Update to PBS Pricing Fact sheet on 'Setting an approved ex manufacturer price for new or extended listings’
15 November 2016 - The PBS Pricing Fact sheet on ‘Setting an approved ex manufacturer price for new or extended listings’ ...
Posted by Michael Wonder on 14 Nov 2016
Why big data should make insurance cheaper
13 November 2016 - Big data should mean lower average insurance premiums, according to a new report by the Actuaries ...
Posted by Michael Wonder on 14 Nov 2016
Bayer warns planned German price curbs may restrict drug access
14 November 2016 - Germany looking at revenue ceiling for drugs in first year. ...